Renal Cell Carcinoma Advanced

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-31
Clinical Trial Update: Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
This clinical trial investigates cabozantinib as monotherapy or in combination with nivolumab for first-line treatment of advanced or metast…